Simon Amy (CIK 1963879) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Sell BEAM (373 shares), Sell BEAM (6,700 shares), Buy BEAM (31,750 shares), Buy BEAM (12,500 shares), Sell BEAM (374 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Beam Therapeutics Inc. (BEAM) | Chief Medical Officer | Sell | 373 | $12,954 |
| 2026-04-06 | Beam Therapeutics Inc. (BEAM) | Chief Medical Officer | Sell | 6,700 | $164,686 |
| 2026-04-02 | Beam Therapeutics Inc. (BEAM) | Chief Medical Officer | Buy | 31,750 | $0 |
| 2026-01-05 | Beam Therapeutics Inc. (BEAM) | Chief Medical Officer | Buy | 12,500 | $0 |
| 2025-07-03 | Beam Therapeutics Inc. (BEAM) | Chief Medical Officer | Sell | 374 | $6,336 |
| 2025-07-03 | Beam Therapeutics Inc. (BEAM) | Chief Medical Officer | Sell | 876 | $17,625 |
| 2025-04-03 | Beam Therapeutics Inc. (BEAM) | Chief Medical Officer | Sell | 9,566 | $175,536 |
| 2025-04-03 | Beam Therapeutics Inc. (BEAM) | Chief Medical Officer | Sell | 20,997 | $372,277 |
| 2025-04-02 | Beam Therapeutics Inc. (BEAM) | Chief Medical Officer | Buy | 27,500 | $0 |
Source: SEC Form 4 filings · as of 2026-07-02